1159600-49-3

Upstream product

• 1159600-45-9 6-[3-(4-chloro-phenyl)-5-methyl-isoxazol-4-ylmethoxy]-nicotinic acid methyl ester 
• 2516-47-4 cyclopropanemethylamine 
• 127426-56-6 [3-(4-chloro-phenyl)-5-methyl-isoxazol-4-yl]-methanol 
• 97026-71-6 (3-(4-chlorophenyl)-5-methyl)isoxazole-4-carboxylic acid ethyl ester 
• 28123-63-9 4-chlorobenzohydroximoyl chloride 
• 3848-36-0 4-chlorobenzaldoxime 
• 104-88-1 4-chlorobenzaldehyde 
• 456-48-4 3-Fluorobenzaldehyde 
• 1159251-38-3 [3-(3-fluoro-phenyl)-5-methyl-isoxazol-4-yl]-methanol 
• 917388-62-6 3-(3-fluoro-phenyl)-5-methyl-isoxazole-4-carboxylic acid ethyl ester 
• 58606-42-1 N-hydroxy-3-fluoro-benzenecarboximidoyl chloride 
• 458-02-6 3-fluorobenzaldehyde oxime 

Relevant academic research and scientific papers

PROCESS FOR THE PREPARATION OF ISOXAZOLYL-METHOXY-NICOTINIC ACIDS

The present invention relates to a process for the preparation of a compound of formula (I) which is useful as an intermediate in the preparation of active pharmaceutical compounds from a compound of formula (IV) wherein R1 and R2 ar

PROCESS FOR THE PREPARATION OF ISOXAZOLYL- METHOXY NICOTINIC ACIDS

The present invention relates to a process for the preparation of a compound of formula (I) wherein R1 and R2 are as defined herein, which is useful as an intermediate in the preparation of active pharmaceutical compounds.

ISOXAZOLE-PYRIDINE DERIVATIVES

The present invention is concerned with isoxazole-pyridine derivatives of formula I wherein X, R1 to R6 are as described herein. The compounds are active on the GABA A α5 receptor binding site and useful for the treatment of cognitive disorders, such as Alzheimer's disease.